Minimally Invasive in Situ Perfusion Method for Targeted AAV Delivery in Native Kidney: Proof of Concept in Pigs
This study demonstrates a proof-of-concept for a minimally invasive, fluoroscopy-guided in situ perfusion technique in pigs that enables efficient, targeted delivery of adeno-associated viruses (AAV) to native kidneys while significantly limiting off-target hepatotoxicity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Chronic kidney disease is a silent, growing burden that affects millions of people worldwide, often leading to a stage where the body can no longer filter waste from the blood. When this happens, patients face a choice between dialysis, a machine that performs the kidney's work, or a transplant. While these options keep people alive, they do not fully restore the complex, natural functions of a healthy organ, and they often come with significant side effects that lower the quality of life. In recent years, scientists have looked toward gene therapy as a way to repair or regenerate damaged kidneys before they fail completely. The most promising tools for this job are tiny, harmless viruses called adeno-associated viruses, which can be engineered to carry genetic instructions into cells. However, a major hurdle has stood in the way of using these viruses for kidney treatment: when injected into the bloodstream, the liver acts like a sponge, soaking up most of the viruses before they ever reach the kidneys. This not only makes the treatment ineffective for the kidneys but also risks damaging the liver.
A team of researchers in Spain has now demonstrated a new way to bypass this problem, proving that it is possible to deliver gene therapy directly to a living kidney without cutting it out of the body. Working with pigs, which have organs similar in size and function to human kidneys, the scientists developed a minimally invasive technique that temporarily isolates a single kidney from the rest of the circulatory system. By threading thin tubes through a small puncture in the leg, they used a balloon to block the artery and vein of the kidney, creating a closed loop. They then pumped a special fluid containing the gene-carrying virus directly into that isolated kidney for one hour. This method allowed the virus to flood the kidney tissue while keeping it out of the bloodstream and away from the liver. Six days later, the researchers found that the genetic instructions had successfully entered the kidney cells, causing them to glow with a specific red light, while the liver showed no signs of having received the virus or suffering any damage.
The procedure was tested on three female pigs, with each animal undergoing the process under general anesthesia. The team used two different types of external perfusion machines, which are devices normally used to keep organs alive outside the body, to maintain the kidney's health during the isolation. One machine was a commercially available device used for preserving kidney grafts, while the other was a pump typically used for heart-lung support. In the first two pigs, the researchers simply tested whether they could successfully isolate the kidney and pump fluid through it without causing harm. They confirmed that the kidney remained viable, with blood flow returning to normal after the procedure, and found only minor, manageable bruising under the skin of the organ. In the third pig, they introduced the virus carrying a gene that makes cells produce a red fluorescent protein. After the hour-long perfusion, the team flushed the kidney with a salt solution to ensure no virus leaked back into the body.
The results showed that the method worked precisely as intended. When the researchers examined the treated pig, they detected the red fluorescent signal only in the kidney that had been perfused, not in the other kidney or in the liver. Microscopic analysis confirmed that the virus had entered the tiny filtering units and tubes of the kidney, including the cells that line the glomeruli, which are the kidney's main filtering structures. The liver, which usually captures these viruses when they are injected into the whole body, showed no evidence of the virus and remained healthy. The researchers also noted that the virus appeared in the bladder, suggesting that some of it was naturally filtered out and excreted in the urine, which may explain why some cells near the kidney's surface were also targeted. Throughout the week following the procedure, the pigs behaved normally, showing no signs of pain or distress, and their kidneys continued to function well.
This study suggests that it is possible to treat a native kidney with gene therapy without the need for major surgery or the risk of liver toxicity. The researchers acknowledge that the sample size was small and that pigs have a higher tendency for blood clots than humans, which could pose challenges if the method is adapted for people. They also noted that the inflammation seen in the treated kidney could be a reaction to the virus or the protein it produced, rather than the procedure itself. However, the success of using two different perfusion systems indicates that the technique is flexible and could be adapted with equipment already available in hospitals. By combining interventional radiology with organ perfusion technology, this approach offers a potential path forward for developing treatments that can repair kidney tissue directly, potentially delaying or preventing the need for dialysis or transplantation in the future.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.